ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Tango Therapeutics
Tango Therapeutics is seeking an Executive Director, Clinical Development to lead the clinical development strategy for its early-stage oncology program TNG456. Reporting to the President of Research & Development, the role involves overseeing protocol design, regulatory strategy, cross‑functional execution, and external scientific engagement, while mentoring medical directors and building high‑performing teams.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tango Therapeutics.
Tango Therapeutics didn’t post a salary, so this is our estimate from similar listings.
5% above the average for this role
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
3 days ago
Medical Director - Hematology
Treeline Biosciences
Medical Director, Clinical Development
Olema Oncology
Executive Director (Distinguished Scientist) and Product Development Team (PDT) Lead
MSD
Global Development Team Lead, Clinical Development – Gastrointestinal Cancers
Revolution Medicines
Global Development Senior Medical Director, Hematology Oncology
AstraZeneca
Senior Director, Clinical Development, Oncology
Moderna
